Citation: hu, j.Md et al.Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis.Journal of cardiac surgery.Sep;33(9):508-519 epub 2018 jul 10.Doi 10.1111/jocs.13767.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via a meta-analysis literature review regarding the implant of transcatheter bioprosthetic valves implanted into failed mitral valves and rings.All data were collected from a pubmed search of articles published between 2000 and march 2018.Sixty-six articles were identified.The overall population included 245 patients.Eighteen patients were implanted with a melody transcatheter bioprosthetic pulmonary valve, implanted in the mitral position.The remaining patients were implanted with a non-medtronic transcatheter bioprosthetic valve.It was reported that the both mosaic and hancock mitral valves had been replaced during the valve-in-valve implants.Serial numbers were not provided.The study population was predominantly male; mean age 73 ± 12.1 years.Among all patients, no deaths were attributed to a medtronic product.Among all patients with a previously implanted mosaic or hancock mitral surgical valve, adverse events included; mitral stenosis, increased mean gradients and mitral regurgitation treated with a valve-in-valve procedure.Based on the available information, these events may have been attributed to a medtronic product.No additional adverse patient effects or product performance issues were reported.
|